StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.66+0.06 (+3.75%)

Close on Nov 17, 2026Market cap $4.22MP/E –Yield –

Alaunos Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Alaunos Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -135266.7%. For fiscal 2025 it was -84500.0%, against -48120.0% the year before. The highest annual figure on record is -336.4% in fiscal 2017.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-84500.0%−36380.0
FY2024Dec 31, 2024-48120.0%+637220.0
FY2023Dec 31, 2023-685340.0%−684138.6
FY2022Dec 31, 2022-1201.4%+18283.3
FY2021Dec 31, 2021-19484.7%+17437.2
FY2018Dec 31, 2018-36921.9%−36585.5
FY2017Dec 31, 2017-336.4%+2072.9
FY2016Dec 31, 2016-2409.4%+10361.8
FY2012Dec 31, 2012-12771.1%−2066.5
FY2011Dec 31, 2011-10704.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-30233.3%+143966.7
Q1 FY2025Mar 31, 2025-54600.0%+740300.0
Q4 FY2024Dec 31, 2024-18875.0%+180675.0
Q2 FY2024Jun 30, 2024-29150.0%+48313.6
Q1 FY2024Mar 31, 2024-174200.0%−173916.1
Q4 FY2023Dec 31, 2023-794900.0%−783806.8
Q2 FY2023Jun 30, 2023-199550.0%−198708.7
Q4 FY2022Dec 31, 2022-77463.6%−76645.2
Q3 FY2022Sep 30, 2022-283.9%+531.0
Q1 FY2018Mar 31, 2018-11093.2%−10218.7
Q4 FY2017Dec 31, 2017-841.3%–
Q3 FY2017Sep 30, 2017-818.4%–
Q2 FY2017Jun 30, 2017-814.9%–
Q1 FY2017Mar 31, 2017-874.5%–

More Alaunos Therapeutics figures

See a number that looks wrong?